Literature DB >> 33180262

Huge hepatocellular carcinoma with extrahepatic collateral arteries successfully treated by multidisciplinary treatment including laparoscopic devascularization: a case report.

Kensuke Yamamura1, Toru Beppu2, Nobutaka Sato1, Eri Oda1, Koichi Kinoshita1, Hideaki Yuki3, Toshihiko Motohara4, Hideaki Miyamoto5, Tsutomu Oda6, Shinichi Akahoshi1.   

Abstract

Multidisciplinary treatment is recommended for the management of patients with advanced hepatocellular carcinoma (HCC). Some operative decollateralization of extrahepatic feeding arteries with laparotomy have been introduced for HCC. We herein newly develop laparoscopic devascularization (LDEV) to continue transarterial chemoembolization (TACE) for HCC with extrahepatic collateral arteries. A 74-year-old man with multiple huge HCC (4 tumors, 18 cm in diameter) and poor liver function (non-alcoholic steatohepatitis, Child-Pugh score 7) was treated with 6 times of chemoembolization in combination with LDEV, 3 times of ablation therapies, and lenvatinib therapy. His tumor markers were triple positive (AFP, 12,906.5 ng/ml; PIVKA-II, 491,743 mAU/ml; AFP-L3, 91.8%) before treatments; however, they all returned to normal limits. Complete response was achieved according to the modified RECIST criteria. Unfortunately, he died 6 months after the final treatment with no recurrence of HCC due to the postoperative complication of primary lung cancer. LDEV is a useful tool to continue effective TACE, and multidisciplinary treatment including chemoembolization and LDEV can cure advanced HCC patients with extrahepatic collaterals and impaired liver function.

Entities:  

Keywords:  Case report; Extrahepatic collateral artery; Hepatocellular carcinoma; Laparoscopic devascularization; Transarterial chemoembolization

Mesh:

Year:  2020        PMID: 33180262     DOI: 10.1007/s12328-020-01286-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  4 in total

1.  [A promising new procedure: laparoscopic devascularization for hepatocellular carcinoma with extra-hepatic feeding arteries].

Authors:  Toru Beppu; Koichi Doi; Teishi Matsuda; Takatoshi Isiko; Tsuyoshi Yamanaka; Michio Ogawa
Journal:  Gan To Kagaku Ryoho       Date:  2002-11

2.  Endoscopic radiofrequency ablation in elderly patients with hepatocellular carcinoma.

Authors:  Koichi Doi; Toru Beppu; Takatoshi Ishiko; Akira Chikamoto; Hiromitsu Hayashi; Katsunori Imai; Hidetoshi Nitta; Yoshifumi Baba; Toshiro Masuda; Kazutoshi Okabe; Masafumi Kuramoto; Keisuke Kudo; Kenichi Ogata; Tetsufumi Ohchi; Hiroshi Takamori; Ken Kikuchi; Hideo Baba
Journal:  Anticancer Res       Date:  2015-05       Impact factor: 2.480

3.  Decollateralization with silicone rubber sheeting for advanced hepatocellular carcinoma: a preliminary report.

Authors:  Y Sasaki; S Imaoka; T Shibata; O Ishikawa; T Iwanaga; H Kasugai; M Fujita
Journal:  Surgery       Date:  1990-11       Impact factor: 3.982

Review 4.  The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.

Authors:  Toru Beppu; Shigeki Nakagawa; Hidetoshi Nitta; Hirohisa Okabe; Takayoshi Kaida; Katsunori Imai; Hiromitsu Hayashi; Yuki Koga; Kunitaka Kuramoto; Daisuke Hashimoto; Yo-Ichi Yamashita; Akira Chikamoto; Takatoshi Ishiko; Hideo Baba
Journal:  J Clin Transl Hepatol       Date:  2017-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.